Controlling particle size of pharmaceutical active ingredients with fixed dosages

APPLICATION

Baclofen

Particle size analysis for the quality control of active pharmaceutical ingredients (API)

Baclofen belongs to the group of drugs of muscle relaxants and is being prescribed as a mono product. Is it primarily used for the treatment of spastic movement disorder, e.g. in instances of multiple sclerosis or spinal cord injury.

Particle size distribution of Baclofen

  • Due to safe handling and solubility, the particle size analysis is performed in hexane
  • Small liquid volume during measurement
  • Ultrasonic dispersion in measuring system prior to measurement
  • Easy and complete cleaning of measuring system
  • Expectation of high measurement frequency

Are you interested in additional content? Please register an account. After confirming the registration link brochures, application notes and other documents on particle measurement will be available for download.

Application strengths

Customer benefits

  • Fast and easy control of micronisation
  • Good reproducibility of method
  • Good system-to-system-comparability allows easy transfer of methods to different production sites
  • Safe control of approval relevant particle size independent of user and location

Typical configurations

HELOS/BR + CUVETTE 50

HELOS/BR + CUVETTE 50

boost: 5

Laser Diffraction | Wet
Size range: 0.25 µm - 3,500 µm
Analysis volume: 30 ml - 50 ml

Show configuration

Suited for

Typical applications

Applied for control of

HELOS/KR + CUVETTE 50

HELOS/KR + CUVETTE 50

boost: 5

Laser Diffraction | Wet
Size range: 0.25 µm - 3,500 µm
Analysis volume: 30 ml - 50 ml

Show configuration

Suited for

Typical applications

Applied for control of

HELOS/BR + SYSIPHUS

HELOS/BR + SYSIPHUS

boost: 5

Laser Diffraction | Wet
Size range: 0.1 µm - 875 µm
Analysis volume: 50 ml

Show configuration

Suited for

Typical applications

Applied for control of